Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House Panel Probes FDA Inspections Of Overseas Device Facilities

This article was originally published in The Gray Sheet

Executive Summary

With Congress increasingly focused on improving safety checks for products imported into the United States, FDA oversight of foreign device manufacturing facilities is getting pulled into the mix

You may also be interested in...



FDA Inspections Of Foreign Device Manufacturers Anemic – GAO Testimony

FDA's effectiveness in conducting device manufacturing inspections overseas was criticized by the Government Accountability Office in testimony before Congress that found overall "weaknesses" in the agency's inspection of medical device manufacturers

FDA Inspections Of Foreign Device Manufacturers Anemic – GAO Testimony

FDA's effectiveness in conducting device manufacturing inspections overseas was criticized by the Government Accountability Office in testimony before Congress that found overall "weaknesses" in the agency's inspection of medical device manufacturers

Capitol Hill Roundup: Many Med-Tech Issues Are In Play For 2008

Health care may not have been the most debated issue on Capitol Hill in 2007, but it was close, and issues impacting the medical technology sector were in abundance

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025598

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel